File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/0090-8258(89)90132-7
- Scopus: eid_2-s2.0-0024372453
- PMID: 2753421
- WOS: WOS:A1989AG45100006
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Primary treatment with vincristine, dactinomycin, and cyclophosphamide in nondysgerminomatous germ cell tumor of the ovary
Title | Primary treatment with vincristine, dactinomycin, and cyclophosphamide in nondysgerminomatous germ cell tumor of the ovary |
---|---|
Authors | |
Issue Date | 1989 |
Publisher | Academic Press. The Journal's web site is located at http://www.elsevier.com/locate/ygyno |
Citation | Gynecologic Oncology, 1989, v. 34 n. 2, p. 155-158 How to Cite? |
Abstract | Thirty-three patients with malignant nondysgerminomatous germ cell tumors were treated with vincristine/dactinomycin/cyclophosphamide regimen. Thirty-two patients were suitable for analysis. The overall cure rate was 68.7%. This is comparable to the cure rate observed in the cisplatin/vinblastin/bleomycin regimen. The roles of second-look laparotomy in malignant germ cell tumor are discussed. |
Persistent Identifier | http://hdl.handle.net/10722/173141 |
ISSN | 2023 Impact Factor: 4.5 2023 SCImago Journal Rankings: 1.627 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wong, LC | en_US |
dc.contributor.author | Ngan, HYS | en_US |
dc.contributor.author | Ma, HK | en_US |
dc.date.accessioned | 2012-10-30T06:28:08Z | - |
dc.date.available | 2012-10-30T06:28:08Z | - |
dc.date.issued | 1989 | en_US |
dc.identifier.citation | Gynecologic Oncology, 1989, v. 34 n. 2, p. 155-158 | en_US |
dc.identifier.issn | 0090-8258 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/173141 | - |
dc.description.abstract | Thirty-three patients with malignant nondysgerminomatous germ cell tumors were treated with vincristine/dactinomycin/cyclophosphamide regimen. Thirty-two patients were suitable for analysis. The overall cure rate was 68.7%. This is comparable to the cure rate observed in the cisplatin/vinblastin/bleomycin regimen. The roles of second-look laparotomy in malignant germ cell tumor are discussed. | en_US |
dc.language | eng | en_US |
dc.publisher | Academic Press. The Journal's web site is located at http://www.elsevier.com/locate/ygyno | en_US |
dc.relation.ispartof | Gynecologic Oncology | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols - Adverse Effects - Therapeutic Use | en_US |
dc.subject.mesh | Cyclophosphamide - Administration & Dosage | en_US |
dc.subject.mesh | Dactinomycin - Administration & Dosage | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Follow-Up Studies | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Ovarian Neoplasms - Drug Therapy | en_US |
dc.subject.mesh | Teratoma - Drug Therapy | en_US |
dc.subject.mesh | Vincristine - Administration & Dosage | en_US |
dc.title | Primary treatment with vincristine, dactinomycin, and cyclophosphamide in nondysgerminomatous germ cell tumor of the ovary | en_US |
dc.type | Article | en_US |
dc.identifier.email | Ngan, HYS:hysngan@hkucc.hku.hk | en_US |
dc.identifier.authority | Ngan, HYS=rp00346 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/0090-8258(89)90132-7 | - |
dc.identifier.pmid | 2753421 | - |
dc.identifier.scopus | eid_2-s2.0-0024372453 | en_US |
dc.identifier.volume | 34 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.spage | 155 | en_US |
dc.identifier.epage | 158 | en_US |
dc.identifier.isi | WOS:A1989AG45100006 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Wong, LC=7402092003 | en_US |
dc.identifier.scopusauthorid | Ngan, HYS=34571944100 | en_US |
dc.identifier.scopusauthorid | Ma, HK=7403095603 | en_US |
dc.identifier.issnl | 0090-8258 | - |